Imara Inc. reports annual meeting results; elects directors, ratifies EY as auditor

Enliven Therapeutics, Inc.

Stockholders elected Rahul D. Ballal and Barbara J. Dalton as Class II directors for three-year terms expiring 2025.
Ballal received 11,789,401 votes for and 1,791,276 withheld; Dalton had 11,786,912 for and 1,793,765 withheld.
Ratification of Ernst & Young as independent auditor for FY 2022 passed with 18,806,373 votes for, 60,227 against, 46,749 abstentions.
Meeting held on June 2, 2022; broker non-votes on director elections totaled 5,332,673.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.